Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PARAOXONASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 285 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yavo, B; Brunetti, IL; da Fonseca, LM; Catalani, LH; Campa, A
      Selective activity of butyrylcholinesterase in serum by a chemiluminescentassay

      LUMINESCENCE
    2. Topic, E; Simundic, AM; Stefanovic, M; Demarin, V; Vukovic, V; Lovrencic-Husjan, A; Zuntar, I
      Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    3. Pallaud, C; Stranieri, C; Sass, C; Siest, G; Pignatti, F; Visvikis, S
      Candidate gene polymorphisms in cardiovascular disease: A comparative study of frequencies between a French and an Italian population

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    4. Axelsson, B; Brattsand, R
      Soft steroids

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    5. Balogh, Z; Seres, I; Harangi, M; Kovacs, P; Kakuk, G; Paragh, G
      Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?

      DIABETES & METABOLISM
    6. Mackness, B; Davies, GK; Turkie, W; Lee, E; Roberts, DH; Hill, E; Roberts, C; Durrington, PN; Mackness, MI
      Paraoxonase status in coronary heart disease - Are activity and concentration more important than genotype?

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    7. La Du, BN
      Is paraoxonase-3 another HDL-associated protein protective against atherosclerosis?

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    8. Durrington, PN; Mackness, B; Mackness, MI
      Paraoxonase and atherosclerosis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    9. Navab, M; Berliner, JA; Subbanagounder, G; Hama, S; Lusis, AJ; Castellani, LW; Reddy, S; Shih, D; Shi, WB; Watson, AD; Van Lenten, BJ; Vora, D; Fogelman, AM
      HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    10. Reddy, ST; Wadleigh, DJ; Grijalva, V; Ng, C; Hama, S; Gangopadhyay, A; Shih, DM; Lusis, AJ; Navab, M; Fogelman, AM
      Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. Senti, M; Tomas, M; Marrugat, J; Elosua, R
      Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarctionrisk associated with decreased HDLs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    12. Malin, R; Laine, S; Rantalaiho, V; Wirto, O; Pasternack, A; Jokela, H; Alho, H; Koivula, T; Lehtimaki, T
      Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers

      FREE RADICAL RESEARCH
    13. Van Lenten, BJ; Navab, M; Shih, D; Fogelman, AM; Lusis, AJ
      The role of high-density lipoproteins in oxidation and inflammation

      TRENDS IN CARDIOVASCULAR MEDICINE
    14. Lee, MS; Cho, SJ; Tak, ES; Koh, KS; Choo, JK; Park, HW; Kim, E; Na, Y; Park, SC
      Partial characterization of phosphotriesterase activity from the earthworm, Eisenia andrei

      INTERNATIONAL BIODETERIORATION & BIODEGRADATION
    15. Malin, R; Laaksonen, R; Knuuti, J; Janatuinen, T; Vesalainen, R; Nuutila, P; Lehtimaki, T
      Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol

      PHARMACOGENETICS
    16. Brophy, VH; Hastings, MD; Clendenning, JB; Richter, RJ; Jarvik, GP; Furlong, CE
      Polymorphisms in the human paraoxonase (PON1) promoter

      PHARMACOGENETICS
    17. Koch, M; Hering, S; Barth, C; Ehren, M; Enderle, MD; Pfohl, M
      Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    18. Luft, FC
      Insecticides and atherosclerosis

      JOURNAL OF MOLECULAR MEDICINE-JMM
    19. Malin, R; Knuuti, J; Janatuinen, T; Laaksonen, R; Vesalainen, R; Nuutila, P; Jokela, H; Laakso, J; Jaakkola, O; Solakivi, T; Lehtimaki, T
      Paraoxonase gene polymorphisms and coronary reactivity in young healthy men

      JOURNAL OF MOLECULAR MEDICINE-JMM
    20. Leviev, N; Righetti, A; James, RW
      Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease

      JOURNAL OF MOLECULAR MEDICINE-JMM
    21. Raveh, O; Pinchuk, I; Fainaru, M; Lichtenberg, D
      Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects

      FREE RADICAL BIOLOGY AND MEDICINE
    22. Osei-Hyiaman, D; Hou, LF; Fan, MB; Ren, ZY; Zhang, ZM; Kano, K
      Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    23. Sanguinetti, SM; Brites, FD; Fasulo, V; Verona, J; Elbert, A; Wikinski, RLW; Schreier, LE
      HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients

      DIABETES NUTRITION & METABOLISM
    24. Jokanovic, M
      Biotransformation of organophosphorus compounds

      TOXICOLOGY
    25. Deeg, MA; Bowen, RF; Williams, MD; Olson, LK; Kirk, EA; Leboeuf, RC
      Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    26. Sozmen, EY; Sozmen, B; Delen, Y; Onat, T
      Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control

      ARCHIVES OF MEDICAL RESEARCH
    27. Vittozzi, L; Fabrizi, L; Di Consiglio, E; Testai, E
      Mechanistic aspects of organophosphorothionate toxicity in fish and humans

      ENVIRONMENT INTERNATIONAL
    28. Sampson, MJ; Astley, S; Richardson, T; Willis, G; Davies, IR; Hughes, DA; Southon, S
      Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation

      CLINICAL SCIENCE
    29. Boullier, A; Hennuyer, N; Tailleux, A; Furman, C; Duverger, N; Caillaud, JM; Castro, G; Fievet, C; Fruchart, JC; Duriez, P
      Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia

      CLINICAL SCIENCE
    30. Galli, F; Varga, Z; Balla, J; Ferraro, B; Canestrari, F; Floridi, A; Kakuk, G; Buoncristiani, U
      Vitamin E, lipid profile, and peroxidation in hemodialysis patients

      KIDNEY INTERNATIONAL
    31. Cowan, J; Sinton, CM; Varley, AW; Wians, FH; Haley, RW; Munford, RS
      Gene therapy to prevent organophosphate intoxication

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    32. Markus, H; Kapozsta, Z; Ditrich, R; Wolfe, C; Ali, N; Powell, J; Mendell, M; Cullinane, M
      Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms

      STROKE
    33. Ferre, N; Camps, J; Cabre, M; Paul, A; Joven, J
      Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis

      METABOLISM-CLINICAL AND EXPERIMENTAL
    34. Akhmedova, SN; Yakimovsky, AK; Schwartz, EI
      Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    35. Kaplan, M; Hayek, T; Raz, A; Coleman, R; Dornfeld, L; Vaya, J; Aviram, M
      Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development ofatherosclerosis

      JOURNAL OF NUTRITION
    36. Navab, M; Hama, SY; Hough, GP; Subbanagounder, G; Reddy, ST; Fogelman, AM
      A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids

      JOURNAL OF LIPID RESEARCH
    37. Brushia, RJ; Forte, TM; Oda, MN; La Du, BN; Bielicki, JK
      Baculovirus-mediated expression and purification of human serum paraoxonase 1A

      JOURNAL OF LIPID RESEARCH
    38. Hedrick, CC; Castellani, LW; Wong, H; Lusis, AJ
      In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions

      JOURNAL OF LIPID RESEARCH
    39. Paolisso, G; Manzella, D; Tagliamonte, MR; Barbieri, M; Marfella, R; Zito, G; Bonafe, M; Giugliano, D; Franceschi, C; Varricchio, M
      The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    40. Motti, C; Dessi, M; Gnasso, A; Irace, C; Indigeno, P; Angelucci, CB; Bernardini, S; Fucci, G; Federici, G; Cortese, C
      A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms

      ATHEROSCLEROSIS
    41. Malin, R; Jarvinen, O; Sisto, T; Koivula, T; Lehtimaki, T
      Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis

      ATHEROSCLEROSIS
    42. Senti, M; Tomas, M; Vila, J; Marrugat, J; Elosua, R; Sala, J; Masia, R
      Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study

      ATHEROSCLEROSIS
    43. Turban, S; Fuentes, F; Ferlic, L; Brugada, R; Gotto, AM; Ballantyne, CM; Marian, AJ
      A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin

      ATHEROSCLEROSIS
    44. Leus, FR; Zwart, M; Kastelein, JJP; Voorbij, HAM
      PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

      ATHEROSCLEROSIS
    45. Jakubowski, H; Ambrosius, WT; Pratt, JH
      Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis

      FEBS LETTERS
    46. Pinizzotto, M; Castillo, E; Fiaux, M; Temler, E; Gaillard, RC; Ruiz, J
      Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes

      DIABETOLOGIA
    47. Toth, PP
      High-density lipoprotein: Epidemiology, metabolism, and antiatherogenic effects

      DM DISEASE-A-MONTH
    48. Hong, SH; Song, J; Min, WK; Kim, JQ
      Genetic variations of the paraoxonase gene in patients with coronary artery disease

      CLINICAL BIOCHEMISTRY
    49. Lorentz, K; Wirtz, W; Weiss, T
      Continuous monitoring of arylesterase in human serum

      CLINICA CHIMICA ACTA
    50. Shah, PK; Kaul, S; Nilsson, J; Cercek, B
      Exploiting the vascular protective effects of high-density lipoprotein andits apolipoproteins - An idea whose time for testing is coming, Part II

      CIRCULATION
    51. Van Lenten, BJ; Wagner, AC; Nayak, DP; Hama, S; Navab, M; Fogelman, AM
      High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection

      CIRCULATION
    52. Rodrigo, L; Hernandez, AF; Lopez-Caballero, JJ; Fernando, G; Pla, A
      Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. implications for its physiological role

      CHEMICO-BIOLOGICAL INTERACTIONS
    53. Oda, MN; Bielicki, JK; Berger, T; Forte, TM
      Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity

      BIOCHEMISTRY
    54. Noto, H; Hashimoto, Y; Satoh, H; Hara, M; Iso-o, N; Togo, M; Kimura, S; Tsukamoto, K
      Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    55. Brophy, VH; Jampsa, RL; Clendenning, JB; McKinstry, LA; Jarvik, GP; Furlong, CE
      Effects of 5 ' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression

      AMERICAN JOURNAL OF HUMAN GENETICS
    56. Zuliani, G; Ble', A; Zanca, R; Munari, MR; Zurlo, A; Vavalle, C; Atti, AR; Fellin, R
      Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia

      ACTA NEUROLOGICA SCANDINAVICA
    57. Fanella, S; Harris, SB; Young, TH; Hanley, AJG; Zinman, B; Connelly, PW; Hegele, RA
      Association between PON1 L/M55 polymorphism and plasma lipoproteins in twoCanadian aboriginal populations

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    58. Karanth, S; Pope, C
      Carboxylesterase and A-esterase activities during maturation and aging: Relationship to the toxicity of chlorpyrifos and parathion in rats

      TOXICOLOGICAL SCIENCES
    59. Furlong, CE
      PON1 status and neurologic symptom complexes in Gulf War veterans

      GENOME RESEARCH
    60. Tomas, M; Senti, M; Garcia-Faria, F; Vila, J; Torrents, A; Covas, M; Marrugat, J
      Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    61. Sen-Banerjee, S; Siles, X; Campos, H
      Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    62. Hedrick, CC; Hassan, K; Hough, GP; Yoo, J; Simzar, S; Quinto, CR; Kim, SM; Dooley, A; Langi, S; Hama, SY; Navab, M; Witztum, JL; Fogelman, AM
      Short-term feeding of atherogenic diet to mice results in reduction of HDLand paraoxonase that may be mediated by an immune mechanism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    63. Schmidt, R; Schmidt, H; Fazekas, F; Kapeller, P; Roob, G; Lechner, A; Kostner, GM; Hartung, HP
      MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms - Three-year follow-up of the Austrian stroke prevention study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    64. Kudchodkar, BJ; Wilson, J; Lacko, A; Dory, L
      Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    65. Jarvik, GP; Rozek, LS; Brophy, VH; Hatsukami, TS; Richter, RJ; Schellenberg, GD; Furlong, CE
      Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    66. De Geest, B; Stengel, D; Landeloos, M; Lox, M; Le Gat, L; Collen, D; Holvoet, P; Ninio, E
      Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factoracetylhydrolase and paraoxonase - Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    67. Kawaguchi, A; Miyao, Y; Noguchi, T; Nonogi, H; Yamagishi, M; Miyatake, K; Kamikubo, Y; Kumeda, K; Tsushima, M; Yamamoto, A; Kato, H
      Intravascular free tissue factor pathway inhibitor is inversely correlatedwith HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    68. Aviram, M
      Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases

      FREE RADICAL RESEARCH
    69. Lambert, M; Boullier, A; Hachulla, E; Fruchart, JC; Teissier, E; Hatron, PY; Duriez, P
      Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

      LUPUS
    70. Li, WF; Costa, LG; Richter, RJ; Hagen, T; Shih, DM; Tward, A; Lusis, AJ; Furlong, CE
      Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds

      PHARMACOGENETICS
    71. Brophy, VH; Jarvik, GP; Richter, RJ; Rozek, LS; Schellenberg, GD; Furlong, CE
      Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype

      PHARMACOGENETICS
    72. Mackness, MI; Durrington, PN; Mackness, B
      How high-density lipoprotein protects against the effects of lipid peroxidation

      CURRENT OPINION IN LIPIDOLOGY
    73. Morena, M; Cristol, JP; Dantoine, T; Carbonneau, MA; Descomps, B; Canaud, B
      Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    74. Senti, M; Aubo, C; Elosua, R; Sala, J; Tomas, M; Marrugat, J
      Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene

      GENETIC EPIDEMIOLOGY
    75. Klemm, T; Paschke, R
      Possible genetic reasons for late complications in diabetes mellitus

      MEDIZINISCHE KLINIK
    76. Taylor, MC; Le Couteur, DG; Mellick, GD; Board, PG
      Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in aCaucasian population

      JOURNAL OF NEURAL TRANSMISSION
    77. Storm, JE; Rozman, KK; Doull, J
      Occupational exposure limits for 30 organophosphate pesticides based on inhibition of red blood cell acetylcholinesterase

      TOXICOLOGY
    78. Frishberg, Y; Toledano, H; Becker-Cohen, R; Feigin, E; Halle, D
      Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis

      AMERICAN JOURNAL OF KIDNEY DISEASES
    79. Haley, RW
      PON1 and low-dose sarin in marmosets

      JOURNAL OF PSYCHOPHARMACOLOGY
    80. Aubo, C; Senti, M; Marrugat, J; Tomas, M; Vila, J; Sala, J; Masia, R
      Risk of myocardial infarction associated with GIn/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

      EUROPEAN HEART JOURNAL
    81. Aynacioglu, AS; Kepekci, Y
      The human paraoxonase Gln-Arg192 (Q/R) polymorphism in Turkish patients with coronary artery disease

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    82. Furlong, CE; Li, WF; Brophy, VH; Jarvik, GP; Richter, RJ; Shih, DM; Lusis, AJ; Costa, LG
      The PON1 gene and detoxication

      NEUROTOXICOLOGY
    83. Furlong, CE; Li, WF; Richter, RJ; Shih, DM; Lusis, AJ; Alleva, E; Costa, LG
      Genetic and temporal determinants of pesticide sensitivity: Role of paraoxonase (PON1)

      NEUROTOXICOLOGY
    84. Hoy, JB; Cornell, JA; Karlix, JL; Schmidt, CJ; Tebbett, IR; van Haaren, F
      Interactions of pyridostigmine bromide, DEET and permethrin alter locomotor behavior of rats

      VETERINARY AND HUMAN TOXICOLOGY
    85. Mackness, B; Durrington, PN; Abuashia, B; Boulton, AJM; Mackness, MI
      Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy

      CLINICAL SCIENCE
    86. Durrington, PN; Mackness, MI
      Still life in oxidation hypothesis of atherogenesis

      LANCET
    87. Faustman, EM; Silbernagel, SM; Fenske, RA; Burbacher, TM; Ponce, RA
      Mechanisms underlying children's susceptibility to environmental toxicants

      ENVIRONMENTAL HEALTH PERSPECTIVES
    88. Zhu, KY; He, FQ
      Elevated esterases exhibiting arylesterase-like characteristics in an organophosphate-resistant clone of the greenbug, Schizaphis graminum (Homoptera: Aphididae)

      PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
    89. Senti, M; Aubo, C; Tomas, M
      Differential effects of smoking on myocardial infarction risk according tothe Gln/Arg 192 variants of the human paraoxonase gene

      METABOLISM-CLINICAL AND EXPERIMENTAL
    90. Inoue, M; Suehiro, T; Nakamura, T; Ikeda, Y; Kumon, Y; Hashimoto, K
      Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes

      METABOLISM-CLINICAL AND EXPERIMENTAL
    91. Jakubowski, H
      Homocysteine thiolactone: Metabolic origin and protein homocysteinylation in humans

      JOURNAL OF NUTRITION
    92. Kudchodkar, BJ; Lacko, AG; Dory, L; Fungwe, TV
      Dietary fat modulates serum paraoxonase 1 activity in rats

      JOURNAL OF NUTRITION
    93. Biggadike, K; Angell, RM; Burgess, CM; Farrell, RM; Hancock, AP; Harker, AJ; Irving, WR; Ioannou, C; Procopiou, PA; Shaw, RE; Solanke, YE; Singh, OMP; Snowden, MA; Stubbs, RJ; Walton, S; Weston, HE
      Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: An ideal plasma inactivation mechanism

      JOURNAL OF MEDICINAL CHEMISTRY
    94. Navab, M; Hama, SY; Cooke, CJ; Anantharamaiah, GM; Chaddha, M; Jin, L; Subbanagounder, G; Faull, KF; Reddy, ST; Miller, NE; Fogelman, AM
      Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1

      JOURNAL OF LIPID RESEARCH
    95. Navab, M; Hama, SY; Anantharamaiah, GM; Hassan, K; Hough, GP; Watson, AD; Reddy, ST; Sevanian, A; Fonarow, GC; Fogelman, AM
      Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3

      JOURNAL OF LIPID RESEARCH
    96. Baker, PW; Rye, KA; Gamble, JR; Vadas, MA; Barter, PJ
      Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression

      JOURNAL OF LIPID RESEARCH
    97. Jakubowski, H
      Calcium-dependent human serum homocysteine thiolactone hydrolase - A protective mechanism against protein N-homocysteinylation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    98. Gardemann, A; Philipp, M; Hess, K; Katz, N; Tillmanns, H; Haberbosch, W
      The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease

      ATHEROSCLEROSIS
    99. Suehiro, T; Nakamura, T; Inoue, M; Shiinoki, T; Ikeda, Y; Kumon, Y; Shindo, M; Tanaka, H; Hashimoto, K
      A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression

      ATHEROSCLEROSIS
    100. Caslake, MJ; Packard, CJ; Suckling, KE; Holmes, SD; Chamberlain, P; Macphee, CH
      Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease

      ATHEROSCLEROSIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 01:03:51